Bixalomer - Amgen/Ilypsa
Alternative Names: AMG223; ASP1585; ILY-101; Kiklin CapsulesLatest Information Update: 05 Nov 2023
At a glance
- Originator Ilypsa
- Developer Amgen; Astellas Pharma
- Class Polymers; Small molecules
- Mechanism of Action Phosphate binding protein modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Hyperphosphataemia